Related Experiment Video
Updated: Apr 17, 2026
10:50
Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
Published on: July 16, 2018
17.1K
Nanosensors for cancer detection.
François Huber1, Hans Peter Lang1, Jiayun Zhang1
1SNI, Swiss Nano Institute, Institute of Physics, University of Basel, Basel, Switzerland.
Swiss Medical Weekly
|February 10, 2015
Summary
Nanomechanical biosensors using atomic force microscopy cantilevers offer label-free cancer biomarker detection. This novel technology surpasses existing methods and enables non-invasive patient assessment through breath analysis.
Area of Science:
- Biotechnology
- Nanotechnology
- Biosensing
Background:
- Cancer is a leading cause of death globally, necessitating advanced detection methods.
- Current cancer detection techniques like histology, ELISA, and PCR have limitations.
- Nanomechanical biosensors offer a promising alternative for sensitive and specific cancer detection.
Purpose of the Study:
- To highlight the potential of nanomechanical biosensors based on atomic force microscopy (AFM) cantilevers for cancer detection.
- To demonstrate the advantages of this technology over existing methods.
- To explore novel applications in biomarker analysis and non-invasive diagnostics.
Main Methods:
- Utilizing atomic force microscopy (AFM) cantilevers as nanomechanical biosensors.
- Developing label-free detection strategies for biomarkers.
- Employing cantilever array formats for complex biological analyses.
Main Results:
- Demonstrated label-free biomarker detection in a cellular background without amplification (e.g., BRAF mutation analysis).
- Enabled analysis of membrane protein dynamics via surface stress changes.
- Showcased non-invasive characterization of exhaled breath for patient assessment.
Conclusions:
- Nanomechanical biosensors represent a versatile and powerful technology for cancer detection and diagnostics.
- This approach offers significant advantages over current methods, including label-free detection and non-invasive capabilities.
- Future applications include advanced biomarker analysis and real-time patient monitoring.
